Yuhan Corporation has invested KRW 3.9 billion additionally to the U.S.-based subsidiary of the company. The company invested KRW 27 billion over the past five years, expanding support for global entry.

According to Financial Supervisory Service on September 4th, Yuhan Corporation invested KRW 3.9 billion in the first half of the year and acquired an additional 3 million shares.

Established in 2018, Yuhan USA is a U.S.-based regional subsidiary of Yuhan Corporation and and is responsible for investing in potential biotech ventures, conducting global clinical trials, and delivering technology transfers. It is Yuhan Corporation's wholly-owned subsidiary and will serve as a bridgehead for g